Innovations in arrhythmia management in pregnant woman: catheter ablation without using fluoroscopy

• DOI: 10.1093/europace/euae102.761
• Publication Date: 2024-05-24T12:36:38Z
• Authors: A Smagulova; B Ainabekova; R Albaev; Z H Abdrakhmanova; Z H Suleymen; A Abdrakhmanov
• Keywords: Cardiac Ablation

Abstract Background The latest data of effectiveness and safety catheter ablation without using fluoroscopy in general population suppose wide this technology. However, on pregnant is limited. Purpose To investigate efficacy women with analyzing obstetric neonatal outcomes. Methods We studied 47 cases (mean age 25.3±3.9 years, mean gestation 23.7 ±3.1 weeks) within 24 month follow-up. Ablation was performed under the guidance CARTO (n=21; 44.7%) Ensite Precision systems (n=26; 55.3%) all cases. Results most common arrhythmia atrioventricular nodal reentrant tachycardia 44.7%), which followed by Wolff–Parkinson–White syndrome (n=15; 31.9%). Cases combination accessory pathways slow conduction ways (n=3, 6.4%), ventricular 6.4%) premature contraction (n=5; 10.6%) were rare. successful cases, procedural time 71.9±14.5 minutes. There one case complication after procedure: ileofemoral thrombosis, treated successfully termination (2.1%). found increased uterine contractile activity placental abruption 4.54% 2.3% respectively. blood flow violation more frequent: 15.9% Obstetric outcomes characterized prevalence vaginal delivery term: 76.6% 95.7% live births normal range fetal birth weight Apgar score (3207.4±485 grams 8.4±1.6 respectively). no incidence mortality recurrence at follow up. Conclusions Catheter can be effectively during good